Pub Date : 2026-12-31Epub Date: 2026-01-14DOI: 10.1080/19932820.2025.2611580
Inas Alhudiri, Fawzi Ebrahim, Adam Elzagheid
A concerning trend has recently emerged in Libya where cancer patients are seeking unproven herbal remedies derived from local Artemisia species driven by circulating claims on social media. These unregulated traditional medicines can interact with standard cancer treatments such as chemotherapy and radiation therapy. Scientific evidence suggests that Artemisia compounds can alter drug metabolism through enzymatic pathways (notably the CYP450 system), potentially neutralizing treatment efficacy or exacerbating systemic toxicity. This letter evaluates the toxicological profile of Artemisia and proposes an ethical framework for patient protection and public health intervention in Libya.
{"title":"Unregulated use of <i>Artemisia</i> in cancer patients in Libya: an emerging ethical and public health concern.","authors":"Inas Alhudiri, Fawzi Ebrahim, Adam Elzagheid","doi":"10.1080/19932820.2025.2611580","DOIUrl":"10.1080/19932820.2025.2611580","url":null,"abstract":"<p><p>A concerning trend has recently emerged in Libya where cancer patients are seeking unproven herbal remedies derived from local Artemisia species driven by circulating claims on social media. These unregulated traditional medicines can interact with standard cancer treatments such as chemotherapy and radiation therapy. Scientific evidence suggests that <i>Artemisia</i> compounds can alter drug metabolism through enzymatic pathways (notably the CYP450 system), potentially neutralizing treatment efficacy or exacerbating systemic toxicity. This letter evaluates the toxicological profile of <i>Artemisia</i> and proposes an ethical framework for patient protection and public health intervention in Libya.</p>","PeriodicalId":49910,"journal":{"name":"Libyan Journal of Medicine","volume":"21 1","pages":"2611580"},"PeriodicalIF":1.7,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12805842/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145967351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-31Epub Date: 2026-02-12DOI: 10.1080/19932820.2026.2630407
Somayeh Haji Ahmadi, Naeimeh Kardanpour, Mohammadreza Elhaie, Mohammad Saleh Jafarpisheh, Peyman Hashemi, Seyyed-Ali Alaei
Hemoptysis, often life-threatening in its massive form, is predominantly caused by bronchial artery pathology. Bronchial artery embolization (BAE) is the established first-line intervention, yet the relationship between bronchial artery morphology and embolization outcomes remains insufficiently defined. This prospective pilot study aimed to assess the association between bronchial artery anatomical features and short-term outcomes following BAE, and to evaluate concordance between computed tomography (CT) angiography and digital subtraction angiography (DSA) in detecting hypertrophy and tortuosity. Twenty-eight patients with hemoptysis requiring BAE were prospectively enrolled in a cohort study. Baseline multidetector CT angiography characterized bronchial artery origin, diameter, hypertrophy, tortuosity, and systemic collaterals. All patients underwent DSA-guided BAE. Treatment success was defined as cessation of hemoptysis within 48 hours, with recurrence assessed at 30 days. Inter-modality agreement was measured using Cohen's kappa. Immediate success was achieved in 92.9% of cases, with recurrence observed in 14.3% at 30 days. No statistically significant associations were found between artery morphology and outcomes. Descriptive trends suggested higher recurrence in patients with systemic collaterals and smaller left bronchial artery diameters (<2 mm). Moderate agreement was observed between CT and DSA for hypertrophy detection (Kappa = 0.563 for right bronchial artery, 0.500 for left), while substantial agreement was found for tortuosity (Kappa = 0.710 and 0.774, respectively). CT angiography demonstrated moderate concordance with DSA for hypertrophy detection (Kappa = 0.563 for right bronchial artery, 0.500 for left), while substantial agreement was found for tortuosity (Kappa = 0.710 and 0.774, respectively). Bronchial artery morphology was not significantly predictive of short-term BAE outcomes, though systemic collaterals and small vessel diameters may contribute to recurrence risk. While moderate agreement limits CTA as a sole tool, it aids in identifying targets efficiently. Larger, multicenter studies are warranted to refine risk stratification and optimize hemoptysis management.
{"title":"Prospective concordance of multidetector CT angiography and digital subtraction angiography in assessing bronchial artery morphology for hemoptysis embolization outcomes.","authors":"Somayeh Haji Ahmadi, Naeimeh Kardanpour, Mohammadreza Elhaie, Mohammad Saleh Jafarpisheh, Peyman Hashemi, Seyyed-Ali Alaei","doi":"10.1080/19932820.2026.2630407","DOIUrl":"10.1080/19932820.2026.2630407","url":null,"abstract":"<p><p>Hemoptysis, often life-threatening in its massive form, is predominantly caused by bronchial artery pathology. Bronchial artery embolization (BAE) is the established first-line intervention, yet the relationship between bronchial artery morphology and embolization outcomes remains insufficiently defined. This prospective pilot study aimed to assess the association between bronchial artery anatomical features and short-term outcomes following BAE, and to evaluate concordance between computed tomography (CT) angiography and digital subtraction angiography (DSA) in detecting hypertrophy and tortuosity. Twenty-eight patients with hemoptysis requiring BAE were prospectively enrolled in a cohort study. Baseline multidetector CT angiography characterized bronchial artery origin, diameter, hypertrophy, tortuosity, and systemic collaterals. All patients underwent DSA-guided BAE. Treatment success was defined as cessation of hemoptysis within 48 hours, with recurrence assessed at 30 days. Inter-modality agreement was measured using Cohen's kappa. Immediate success was achieved in 92.9% of cases, with recurrence observed in 14.3% at 30 days. No statistically significant associations were found between artery morphology and outcomes. Descriptive trends suggested higher recurrence in patients with systemic collaterals and smaller left bronchial artery diameters (<2 mm). Moderate agreement was observed between CT and DSA for hypertrophy detection (Kappa = 0.563 for right bronchial artery, 0.500 for left), while substantial agreement was found for tortuosity (Kappa = 0.710 and 0.774, respectively). CT angiography demonstrated moderate concordance with DSA for hypertrophy detection (Kappa = 0.563 for right bronchial artery, 0.500 for left), while substantial agreement was found for tortuosity (Kappa = 0.710 and 0.774, respectively). Bronchial artery morphology was not significantly predictive of short-term BAE outcomes, though systemic collaterals and small vessel diameters may contribute to recurrence risk. While moderate agreement limits CTA as a sole tool, it aids in identifying targets efficiently. Larger, multicenter studies are warranted to refine risk stratification and optimize hemoptysis management.</p>","PeriodicalId":49910,"journal":{"name":"Libyan Journal of Medicine","volume":"21 1","pages":"2630407"},"PeriodicalIF":1.7,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12903930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146167534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-31Epub Date: 2026-02-07DOI: 10.1080/19932820.2026.2626625
Amin Bredan
Research performance in the Middle East and North Africa (MENA) is often assessed using national aggregates that mask substantial institutional variation. Evidence on how output, quality, and excellence relate to economic resources and institutional capacity across the region remains limited. Data from the SCImago Research Centers Rankings were used to analyze 321 non-university, non-health research centers across 22 MENA countries. Indicators included research output, Quality, Excellence, collaboration, innovation, and Institutional Citation Impact per researcher (ICI/T). Analyses were conducted at both country and institutional levels using descriptive statistics, correlation analysis, and clustering. The analysis reveals extreme heterogeneity within and across countries. National income is strongly associated with research Excellence but shows a much weaker relationship with baseline Quality. ICI/T is strongly associated with Excellence and displays reduced variance at higher values, indicating increasing stability of elite performance. Clustering identifies multiple tiers of research systems that cut across income categories. A small group of countries exhibits disproportionately high Excellence relative to weak institutional impact, consistent with structural decoupling. International collaboration supports Quality but does not predict Excellence, while regional and industry collaboration remain limited. Economic resources accelerate elite research performance but do not guarantee high baseline quality. Long-term research performance in the MENA region depends primarily on institutional alignment, governance, and sustained capacity building rather than output expansion alone.
{"title":"Comparative analysis of research quantity, quality, and impact in MENA research centers.","authors":"Amin Bredan","doi":"10.1080/19932820.2026.2626625","DOIUrl":"10.1080/19932820.2026.2626625","url":null,"abstract":"<p><p>Research performance in the Middle East and North Africa (MENA) is often assessed using national aggregates that mask substantial institutional variation. Evidence on how output, quality, and excellence relate to economic resources and institutional capacity across the region remains limited. Data from the SCImago Research Centers Rankings were used to analyze 321 non-university, non-health research centers across 22 MENA countries. Indicators included research output, Quality, Excellence, collaboration, innovation, and Institutional Citation Impact per researcher (ICI/T). Analyses were conducted at both country and institutional levels using descriptive statistics, correlation analysis, and clustering. The analysis reveals extreme heterogeneity within and across countries. National income is strongly associated with research Excellence but shows a much weaker relationship with baseline Quality. ICI/T is strongly associated with Excellence and displays reduced variance at higher values, indicating increasing stability of elite performance. Clustering identifies multiple tiers of research systems that cut across income categories. A small group of countries exhibits disproportionately high Excellence relative to weak institutional impact, consistent with structural decoupling. International collaboration supports Quality but does not predict Excellence, while regional and industry collaboration remain limited. Economic resources accelerate elite research performance but do not guarantee high baseline quality. Long-term research performance in the MENA region depends primarily on institutional alignment, governance, and sustained capacity building rather than output expansion alone.</p>","PeriodicalId":49910,"journal":{"name":"Libyan Journal of Medicine","volume":"21 1","pages":"2626625"},"PeriodicalIF":1.7,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885013/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146138107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-31Epub Date: 2026-03-17DOI: 10.1080/19932820.2026.2642992
Suhailah S Aljameel, Mohamed E Eissa, Zinab Alatawi, Hanadi A Alahmadi, Mohammad E Azab, Tarek A Yousef, Sayed K Ramadan, Hasan A Aljohi, Eida S Al-Farraj, Eman Abdullah Bahattab, Ahmed Ghareeb, Eman A E El-Helw
Pyrazole derivatives are a class of heterocyclic compounds known to have broad pharmacological effects. This study aimed to synthesize and characterize a new series of pyrazole derivatives and investigate their effects on a series of in vitro assays. Five synthesized compounds were confirmed structurally using standard spectroscopic techniques, and their cytotoxic activity was evaluated against HeLa cells using MTT assay and morphological examination of viability. DNA damage and fragmentation were analyzed using a comet assay, agarose gel electrophoresis, and diphenylamine reaction. Antioxidant properties were evaluated with radical scavenging assays, and anti-inflammatory potential was assessed with in vitro inhibition assays (COX-1/2). Pyrazolethione 5 showed antiproliferative effects at all concentrations, with preserved cell confluence at ≤62.5 µg/mL. It also demonstrates DPPH scavenging activity similar to that of ascorbic acid in a dose-dependent manner, reaching a maximum activity of 85.9% with an IC₅₀ of 48.77. In addition, it demonstrated antioxidant activity, although significantly lower than that of gallic acid, with a maximum scavenging percentage of 83.9% at 1000 μg/mL and an IC50 of 54.97 μg/mL. In the comet assay, the treatment significantly increased DNA fragmentation to 26.2% ± 0.88% from 12.8% ± 0.77% in the control cells (p < 0.01), representing a two-fold induction of apoptosis. The test compound inhibited COX-1 in a dose-dependent manner (86.29% inhibition at 1000 µg/mL), producing an IC50 value of 29.14 ± 0.97 µg/mL, while it produced moderate inhibition of COX-2, 82.03% inhibition at 1000 µg/mL, and had an IC50 value of 51.49 ± 2.13 µg/mL. According to flow cytometry analysis, untreated HeLa cells were mainly in G1 (54.56%) and G0 (34.86%), with fewer cells in S (9.63%), and G2-M (0.94%). In pyrazolethione-treated HeLa cells, G0 accumulation (73.57%) and fewer proliferative phases (S 3.10% and G2-M 2.78%) indicated substantial alteration to the cell cycle. Pyrazolethione 5 demonstrates a favorable safety profile, with minimal cytotoxicity at lower concentrations, and impressive antioxidant and anti-inflammatory activities. The DPPH and gallic acid-like radical scavenging activities, moderate COX-1 and COX-2 inhibition, and DNA fragmentation suggest multiple bioactivities. Furthermore, the compound significantly altered cell cycle progression in HeLa cells, leading to G0/G1 arrest and reduced proliferation. Taken together, the data indicate pyrazolethione 5 is a potential lead compound for further development/investigation as an anticancer and anti-inflammatory agent with low toxicity.
{"title":"Multi-targeted pyrazole scaffolds: synthesis, mechanistic insights, and therapeutic potential in anticancer, antioxidant, and anti-inflammatory applications.","authors":"Suhailah S Aljameel, Mohamed E Eissa, Zinab Alatawi, Hanadi A Alahmadi, Mohammad E Azab, Tarek A Yousef, Sayed K Ramadan, Hasan A Aljohi, Eida S Al-Farraj, Eman Abdullah Bahattab, Ahmed Ghareeb, Eman A E El-Helw","doi":"10.1080/19932820.2026.2642992","DOIUrl":"10.1080/19932820.2026.2642992","url":null,"abstract":"<p><p>Pyrazole derivatives are a class of heterocyclic compounds known to have broad pharmacological effects. This study aimed to synthesize and characterize a new series of pyrazole derivatives and investigate their effects on a series of <i>in vitro</i> assays. Five synthesized compounds were confirmed structurally using standard spectroscopic techniques, and their cytotoxic activity was evaluated against HeLa cells using MTT assay and morphological examination of viability. DNA damage and fragmentation were analyzed using a comet assay, agarose gel electrophoresis, and diphenylamine reaction. Antioxidant properties were evaluated with radical scavenging assays, and anti-inflammatory potential was assessed with <i>in vitro</i> inhibition assays (COX-1/2). Pyrazolethione <b>5</b> showed antiproliferative effects at all concentrations, with preserved cell confluence at ≤62.5 µg/mL. It also demonstrates DPPH scavenging activity similar to that of ascorbic acid in a dose-dependent manner, reaching a maximum activity of 85.9% with an IC₅₀ of 48.77. In addition, it demonstrated antioxidant activity, although significantly lower than that of gallic acid, with a maximum scavenging percentage of 83.9% at 1000 μg/mL and an IC<sub>50</sub> of 54.97 μg/mL. In the comet assay, the treatment significantly increased DNA fragmentation to 26.2% ± 0.88% from 12.8% ± 0.77% in the control cells (<i>p </i>< 0.01), representing a two-fold induction of apoptosis. The test compound inhibited COX-1 in a dose-dependent manner (86.29% inhibition at 1000 µg/mL), producing an IC<sub>50</sub> value of 29.14 ± 0.97 µg/mL, while it produced moderate inhibition of COX-2, 82.03% inhibition at 1000 µg/mL, and had an IC<sub>50</sub> value of 51.49 ± 2.13 µg/mL. According to flow cytometry analysis, untreated HeLa cells were mainly in G1 (54.56%) and G0 (34.86%), with fewer cells in S (9.63%), and G2-M (0.94%). In pyrazolethione-treated HeLa cells, G0 accumulation (73.57%) and fewer proliferative phases (S 3.10% and G2-M 2.78%) indicated substantial alteration to the cell cycle. Pyrazolethione <b>5</b> demonstrates a favorable safety profile, with minimal cytotoxicity at lower concentrations, and impressive antioxidant and anti-inflammatory activities. The DPPH and gallic acid-like radical scavenging activities, moderate COX-1 and COX-2 inhibition, and DNA fragmentation suggest multiple bioactivities. Furthermore, the compound significantly altered cell cycle progression in HeLa cells, leading to G0/G1 arrest and reduced proliferation. Taken together, the data indicate pyrazolethione <b>5</b> is a potential lead compound for further development/investigation as an anticancer and anti-inflammatory agent with low toxicity.</p>","PeriodicalId":49910,"journal":{"name":"Libyan Journal of Medicine","volume":"21 1","pages":"2642992"},"PeriodicalIF":1.7,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12997473/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-31Epub Date: 2026-03-17DOI: 10.1080/19932820.2026.2642904
Purnima Adhikari, Raju Rana, Rohini Punja, Prakashini Koteshwar, Rahul Magazine, Mohan K Manu, Santa Kumar Das, Sharma Paudel, Chandni Gupta
Hyponatremia has been found to be associated with chronic obstructive pulmonary disease (COPD) and acute exacerbations of chronic obstructive pulmonary disease (AECOPD). However, there is a lack of systematic evidence on the prevalence and impact of hyponatremia in COPD and AECOPD patients. We performed a systematic search on three major databases for articles published on or before 31 July 2025. We included all the studies reporting the prevalence or number of hyponatremia cases in COPD patients (stable and exacerbation) aged 18 years and above. Pooled prevalence was calculated by a random effects model using RStudio. The Joanna Briggs Institute (JBI) tool was used for quality evaluation of the included studies. In this systematic review and meta-analysis, we included 11 studies out of 284 studies retrieved in the initial search. Of these 11 studies, three were COPD studies, and eight were AECOPD studies. The pooled prevalence of hyponatremia among COPD patients was 14% (95% CI: 4%-28%), with significant heterogeneity (I² = 98.3%, p < 0.0001). The pooled prevalence of hyponatremia in AECOPD patients was 19% (95% CI: 9%-32%), with significant heterogeneity (I² = 98.8%, p < 0.0001). Most of the studies showed that hyponatremia was not associated with mortality as an outcome of AECOPD. This study found a high prevalence of hyponatremia in both COPD and AECOPD patients; however, substantial heterogeneity (I² > 98%) necessitates cautious interpretation of pooled estimates. Future studies with standardized diagnostic criteria and larger sample sizes are needed to establish more precise prevalence rates.
低钠血症已被发现与慢性阻塞性肺疾病(COPD)和慢性阻塞性肺疾病(AECOPD)急性加重有关。然而,关于低钠血症在COPD和AECOPD患者中的患病率和影响,缺乏系统的证据。我们对2025年7月31日或之前发表的文章在三个主要数据库中进行了系统检索。我们纳入了所有报道18岁及以上COPD患者(稳定型和加重型)低钠血症患病率或数量的研究。合并患病率采用RStudio随机效应模型计算。采用Joanna Briggs Institute (JBI)工具对纳入的研究进行质量评价。在这项系统综述和荟萃分析中,我们从最初检索到的284项研究中纳入了11项研究。在这11项研究中,3项是COPD研究,8项是AECOPD研究。COPD患者中低钠血症的合并患病率为14% (95% CI: 4%-28%),存在显著的异质性(I²= 98.3%,p²= 98.8%,p²> 98%),需要对合并估计进行谨慎解释。未来的研究需要标准化的诊断标准和更大的样本量来确定更精确的患病率。
{"title":"Prevalence and impact of hyponatremia in chronic obstructive pulmonary disease. A systematic review and meta-analysis.","authors":"Purnima Adhikari, Raju Rana, Rohini Punja, Prakashini Koteshwar, Rahul Magazine, Mohan K Manu, Santa Kumar Das, Sharma Paudel, Chandni Gupta","doi":"10.1080/19932820.2026.2642904","DOIUrl":"10.1080/19932820.2026.2642904","url":null,"abstract":"<p><p>Hyponatremia has been found to be associated with chronic obstructive pulmonary disease (COPD) and acute exacerbations of chronic obstructive pulmonary disease (AECOPD). However, there is a lack of systematic evidence on the prevalence and impact of hyponatremia in COPD and AECOPD patients. We performed a systematic search on three major databases for articles published on or before 31 July 2025. We included all the studies reporting the prevalence or number of hyponatremia cases in COPD patients (stable and exacerbation) aged 18 years and above. Pooled prevalence was calculated by a random effects model using RStudio. The Joanna Briggs Institute (JBI) tool was used for quality evaluation of the included studies. In this systematic review and meta-analysis, we included 11 studies out of 284 studies retrieved in the initial search. Of these 11 studies, three were COPD studies, and eight were AECOPD studies. The pooled prevalence of hyponatremia among COPD patients was 14% (95% CI: 4%-28%), with significant heterogeneity (<i>I</i>² = 98.3%, <i>p </i>< 0.0001). The pooled prevalence of hyponatremia in AECOPD patients was 19% (95% CI: 9%-32%), with significant heterogeneity (<i>I</i>² = 98.8%, <i>p </i>< 0.0001). Most of the studies showed that hyponatremia was not associated with mortality as an outcome of AECOPD. This study found a high prevalence of hyponatremia in both COPD and AECOPD patients; however, substantial heterogeneity (<i>I</i>² > 98%) necessitates cautious interpretation of pooled estimates. Future studies with standardized diagnostic criteria and larger sample sizes are needed to establish more precise prevalence rates.</p>","PeriodicalId":49910,"journal":{"name":"Libyan Journal of Medicine","volume":"21 1","pages":"2642904"},"PeriodicalIF":1.7,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13003898/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147476120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-31Epub Date: 2025-12-27DOI: 10.1080/19932820.2025.2598896
Ben Amer M Antisar, Omar M Enas, Elsheikh M Sahar, Musrati S Ahmed
EMMPRIN is a widely distributed cell surface glycoprotein that belongs to the immunoglobulin (Ig) superfamily. It induces the production of extracellular matrix metalloproteinases (MMPs) and plays an important role in angiogenesis via stimulation of vascular endothelial growth factor (VEGF). The aim of the present work was to assess and compare the expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in different oral nonodontogenic carcinomas. Fifty-four diagnosed cases of oral nonodontogenic carcinomas were selected, and biopsies were taken from the tumor tissue, fixed, processed, and cut into sections to be stained with hematoxylin and eosin (H&E) for routine histopathological examination. Immunohistochemistry was performed for EMMPRIN. All cases showed positive EMMPRIN expression with different intensities. The results were recorded and statistically analyzed using student t-test, Pearson correlation, test and ANOVA test. This study concluded that elevated EMMPRIN expression is correlated with tumor proliferation, angiogenesis, metastasis, and invasion.
{"title":"Expression of EMMPRIN as a biomarker in nonodontogenic carcinomas: a histological study.","authors":"Ben Amer M Antisar, Omar M Enas, Elsheikh M Sahar, Musrati S Ahmed","doi":"10.1080/19932820.2025.2598896","DOIUrl":"10.1080/19932820.2025.2598896","url":null,"abstract":"<p><p>EMMPRIN is a widely distributed cell surface glycoprotein that belongs to the immunoglobulin (Ig) superfamily. It induces the production of extracellular matrix metalloproteinases (MMPs) and plays an important role in angiogenesis via stimulation of vascular endothelial growth factor (VEGF). The aim of the present work was to assess and compare the expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in different oral nonodontogenic carcinomas. Fifty-four diagnosed cases of oral nonodontogenic carcinomas were selected, and biopsies were taken from the tumor tissue, fixed, processed, and cut into sections to be stained with hematoxylin and eosin (H&E) for routine histopathological examination. Immunohistochemistry was performed for EMMPRIN. All cases showed positive EMMPRIN expression with different intensities. The results were recorded and statistically analyzed using student <i>t</i>-test, Pearson correlation, test and ANOVA test. This study concluded that elevated EMMPRIN expression is correlated with tumor proliferation, angiogenesis, metastasis, and invasion.</p>","PeriodicalId":49910,"journal":{"name":"Libyan Journal of Medicine","volume":"21 1","pages":"2598896"},"PeriodicalIF":1.7,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12777829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145846895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-31Epub Date: 2026-02-07DOI: 10.1080/19932820.2026.2625359
James J Yahaya, Angelina A Joho
Assessment of risk factors of breast cancer in the general population provides insightful information towards prevention of breast cancer. This study aimed to assess the risk factors of breast cancer among women in a community from a resource-limited setting in sub-Saharan Africa. This descriptive community-based cross-sectional study was conducted in Dodoma, Tanzania, from July to December 2020. The study included women aged between 18 and 70 years. The data were analyzed using SPSS program version 25.0. Independent t-test was used to compare the mean age of the participants for the availability of risk factors of breast cancer. A two-tailed p < 0.05 was considered significant. A total of 354 women were analyzed, and the median age was 27.0 (23.0-35.3) years. Only 11.8% (n = 18) of all the participants did not have any of the risk factors examined. Not engaging in physical activity was the most frequent risk factor which accounted for 68.2% (n = 242) of all the participants. There were more 60.7% (n = 215) of the study participants with a low mean age (22.9 ± 3.5) who had more than 5 risk factors compared to 39.3% (n = 139) of the participants with a high mean age (25.3 ± 9.4) who had more than 5 risk factors, with no statistically significant difference (95% CI = 0.91-2.22, p = 0.31). There is a large proportion of women younger than 40 years in the population of Tanzanian women with many risk factors of breast cancer. This may contribute to the currently observed increase in the incidence of breast cancer in Tanzania for women aged less than 40 years. Therefore, there is an urgency for targeted awareness and screening for breast cancer among younger women in Tanzania so as to increase early detection and diagnosis.
对普通人群乳腺癌危险因素的评估为预防乳腺癌提供了有见地的信息。本研究旨在评估撒哈拉以南非洲一个资源有限的社区妇女患乳腺癌的危险因素。这项描述性社区横断面研究于2020年7月至12月在坦桑尼亚多多马进行。研究对象是年龄在18岁到70岁之间的女性。数据采用SPSS 25.0软件进行分析。采用独立t检验比较参与者的平均年龄与乳腺癌危险因素的可得性。所有参与者的双尾p n = 18)没有检查任何风险因素。不参加体育活动是最常见的危险因素,占所有参与者的68.2% (n = 242)。低平均年龄组(22.9±3.5)有超过5个危险因素的受试者较多(60.7%,n = 215),高平均年龄组(25.3±9.4)有超过5个危险因素的受试者较多(39.3%,n = 139),差异无统计学意义(95% CI = 0.91-2.22, p = 0.31)。在坦桑尼亚妇女人口中,40岁以下的妇女占很大比例,她们有许多患乳腺癌的危险因素。这可能是目前观察到的坦桑尼亚40岁以下妇女乳腺癌发病率增加的原因。因此,迫切需要在坦桑尼亚的年轻妇女中有针对性地提高对乳腺癌的认识和筛查,以便增加早期发现和诊断。
{"title":"Assessment of risk factors of breast cancer among women in Dodoma, Tanzania: a community-based cross-sectional study.","authors":"James J Yahaya, Angelina A Joho","doi":"10.1080/19932820.2026.2625359","DOIUrl":"10.1080/19932820.2026.2625359","url":null,"abstract":"<p><p>Assessment of risk factors of breast cancer in the general population provides insightful information towards prevention of breast cancer. This study aimed to assess the risk factors of breast cancer among women in a community from a resource-limited setting in sub-Saharan Africa. This descriptive community-based cross-sectional study was conducted in Dodoma, Tanzania, from July to December 2020. The study included women aged between 18 and 70 years. The data were analyzed using SPSS program version 25.0. Independent <i>t</i>-test was used to compare the mean age of the participants for the availability of risk factors of breast cancer. A two-tailed <i>p</i> < 0.05 was considered significant. A total of 354 women were analyzed, and the median age was 27.0 (23.0-35.3) years. Only 11.8% (<i>n</i> = 18) of all the participants did not have any of the risk factors examined. Not engaging in physical activity was the most frequent risk factor which accounted for 68.2% (<i>n</i> = 242) of all the participants. There were more 60.7% (<i>n</i> = 215) of the study participants with a low mean age (22.9 ± 3.5) who had more than 5 risk factors compared to 39.3% (<i>n</i> = 139) of the participants with a high mean age (25.3 ± 9.4) who had more than 5 risk factors, with no statistically significant difference (95% CI = 0.91-2.22, <i>p</i> = 0.31). There is a large proportion of women younger than 40 years in the population of Tanzanian women with many risk factors of breast cancer. This may contribute to the currently observed increase in the incidence of breast cancer in Tanzania for women aged less than 40 years. Therefore, there is an urgency for targeted awareness and screening for breast cancer among younger women in Tanzania so as to increase early detection and diagnosis.</p>","PeriodicalId":49910,"journal":{"name":"Libyan Journal of Medicine","volume":"21 1","pages":"2625359"},"PeriodicalIF":1.7,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885018/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146133470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Effective diabetes care must address not just the clinical metrics but also this psychological interplay, empowering patients to drive the proactive engagement needed for long-term health. This study aims to explore the mediating effect of the patient activation role on diabetes self-care adherence and diabetes distress. A cross-sectional study was conducted with a convenience sample of 428 adults with type 2 diabetes recruited from diabetes clinics. Participants completed validated surveys through the Patient Activation Measure, Diabetes Distress Scale, and Summary of Diabetes Self-Care Activities. The data were analyzed using correlation and structural equation modeling to test the proposed mediation model. Significant negative correlations were found between patient activation and diabetes distress (r = 0.310, p< 0.001), and positive correlations were found between patient activation and self-care adherence (r = 0.588, p < 0.001). As hypothesized, patient activation significantly mediated the relationship between higher self-care adherence and lower diabetes distress, accounting for 45% of the total effect (indirect effect: β = -0.268). These findings demonstrate that patient activation is a key mechanism through which self-care adherence reduces diabetes distress. This suggests that interventions specifically designed to enhance patient activation can break the cycle of distress by empowering individuals to engage more effectively in self-care behaviors, ultimately improving both psychological and clinical outcomes in diabetes management. Integrating routine assessments of patient activation and distress into clinical practice is recommended.
有效的糖尿病护理不仅要解决临床指标,还要解决这种心理相互作用,使患者能够推动长期健康所需的积极参与。本研究旨在探讨患者激活作用对糖尿病自我护理依从性和糖尿病痛苦的中介作用。一项横断面研究从糖尿病诊所招募了428名成人2型糖尿病患者。参与者通过患者激活测量、糖尿病痛苦量表和糖尿病自我护理活动总结完成了有效的调查。采用相关模型和结构方程模型对数据进行分析,以检验本文提出的中介模型。患者激活与糖尿病窘迫之间存在显著负相关(r = 0.310, pr = 0.588, p β = -0.268)。这些发现表明,患者激活是自我护理依从性减少糖尿病痛苦的关键机制。这表明,专门设计用于增强患者激活的干预措施可以通过使个体更有效地参与自我护理行为来打破痛苦的循环,最终改善糖尿病管理的心理和临床结果。建议将患者激活和痛苦的常规评估纳入临床实践。
{"title":"Breaking the cycle: patient activation role in improving diabetes self-care adherence for alleviating diabetes distress.","authors":"Mohamed Gamal Elsehrawy, Faisal Khalaf Alanazi, Hassanat Ramadan Abdel-Aziz, Mona Mohamed Abdelaziz Barakat, Nermen Abdelftah Mohamed, Mahitab Mohamed Abdelrahman","doi":"10.1080/19932820.2026.2644567","DOIUrl":"10.1080/19932820.2026.2644567","url":null,"abstract":"<p><p>Effective diabetes care must address not just the clinical metrics but also this psychological interplay, empowering patients to drive the proactive engagement needed for long-term health. This study aims to explore the mediating effect of the patient activation role on diabetes self-care adherence and diabetes distress. A cross-sectional study was conducted with a convenience sample of 428 adults with type 2 diabetes recruited from diabetes clinics. Participants completed validated surveys through the Patient Activation Measure, Diabetes Distress Scale, and Summary of Diabetes Self-Care Activities. The data were analyzed using correlation and structural equation modeling to test the proposed mediation model. Significant negative correlations were found between patient activation and diabetes distress (<i>r </i>= 0.310, <i>p</i>< 0.001), and positive correlations were found between patient activation and self-care adherence (<i>r</i> = 0.588, <i>p </i>< 0.001). As hypothesized, patient activation significantly mediated the relationship between higher self-care adherence and lower diabetes distress, accounting for 45% of the total effect (indirect effect: <i>β </i>= -0.268). These findings demonstrate that patient activation is a key mechanism through which self-care adherence reduces diabetes distress. This suggests that interventions specifically designed to enhance patient activation can break the cycle of distress by empowering individuals to engage more effectively in self-care behaviors, ultimately improving both psychological and clinical outcomes in diabetes management. Integrating routine assessments of patient activation and distress into clinical practice is recommended.</p>","PeriodicalId":49910,"journal":{"name":"Libyan Journal of Medicine","volume":"21 1","pages":"2644567"},"PeriodicalIF":1.7,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13003855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147476114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Preoperative anxiety is a feeling of insecurity, physical and psychological discomfort that arises from the prospect of undergoing surgery. Managing anxiety is a therapeutic cornerstone in anesthetic care. Virtual reality has shown a significant effect on managing anxiety and pain by leveraging the principle of distraction, hypnosis, or a combination of distraction and relaxation. We aim to study the impact of virtual reality on perioperative anxiety during surgeries performed under regional anesthesia. This was a monocentric, prospective, randomized study conducted over a three-month period from March 2023 to May 2023 in the anesthesia and resuscitation department of Taher Sfar Hospital in Mahdia. A total of 72 patients scheduled for orthopedic surgeries were included. Patients were randomized to be allocated to: VR+ group (n = 36), who experienced virtual reality during the operation, or the VR- group (n = 36), who did not experience virtual reality. The consumption of anxiolytics (Midazolam) was evaluated intraoperatively along with perioperative anxiety levels (ICD-11 code MB24.6). Anxiety levels were assessed using the STAI-6, and LIKERT scales. Patient satisfaction was measured using the LIKERT scale. Data from 68 patients were analyzed, with 34 patients in each group. Our study showed that there were no significant differences in preoperative anxiety levels between the groups (average STAI-6 score: VR- = 43.2 vs. VR+ = 44.8). Virtual reality reduced the frequency of anxiolytic use intraoperatively: 61.7% in the VR- group vs. 5.8% in the VR+ group (p < 0.001), as well as the quantity used. Postoperative anxiety reduction was comparable between groups. All patients included in the study exhibited very low anxiety levels according to the STAI-6 score, taking preoperative anxiety levels into account. Virtual reality can be considered an effective method for managing perioperative anxiety during surgeries under regional anesthesia and helps prevent postoperative complications.
{"title":"Virtual reality and perioperative anxiety: a randomized controlled trial.","authors":"Mouna Ouaz, Zayati Mohamed, Khalifa Issam, Bannour Imen, Attia Hela, Majdoub Ali","doi":"10.1080/19932820.2026.2616840","DOIUrl":"10.1080/19932820.2026.2616840","url":null,"abstract":"<p><p>Preoperative anxiety is a feeling of insecurity, physical and psychological discomfort that arises from the prospect of undergoing surgery. Managing anxiety is a therapeutic cornerstone in anesthetic care. Virtual reality has shown a significant effect on managing anxiety and pain by leveraging the principle of distraction, hypnosis, or a combination of distraction and relaxation. We aim to study the impact of virtual reality on perioperative anxiety during surgeries performed under regional anesthesia. This was a monocentric, prospective, randomized study conducted over a three-month period from March 2023 to May 2023 in the anesthesia and resuscitation department of Taher Sfar Hospital in Mahdia. A total of 72 patients scheduled for orthopedic surgeries were included. Patients were randomized to be allocated to: VR+ group (<i>n</i> = 36), who experienced virtual reality during the operation, or the VR- group (<i>n</i> = 36), who did not experience virtual reality. The consumption of anxiolytics (Midazolam) was evaluated intraoperatively along with perioperative anxiety levels (ICD-11 code MB24.6). Anxiety levels were assessed using the STAI-6, and LIKERT scales. Patient satisfaction was measured using the LIKERT scale. Data from 68 patients were analyzed, with 34 patients in each group. Our study showed that there were no significant differences in preoperative anxiety levels between the groups (average STAI-6 score: VR- = 43.2 vs. VR+ = 44.8). Virtual reality reduced the frequency of anxiolytic use intraoperatively: 61.7% in the VR- group vs. 5.8% in the VR+ group (<i>p</i> < 0.001), as well as the quantity used. Postoperative anxiety reduction was comparable between groups. All patients included in the study exhibited very low anxiety levels according to the STAI-6 score, taking preoperative anxiety levels into account. Virtual reality can be considered an effective method for managing perioperative anxiety during surgeries under regional anesthesia and helps prevent postoperative complications.</p>","PeriodicalId":49910,"journal":{"name":"Libyan Journal of Medicine","volume":"21 1","pages":"2616840"},"PeriodicalIF":1.7,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12821343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-31Epub Date: 2025-10-14DOI: 10.1080/19932820.2025.2569151
Asma A Al Bijou, Jehan A Ilfergani, Tarek S Bader, Muetaz M Feetouri, Ibtihag S Alogali, Yousef M A Hasen, Mahmoud A Aloriby, Farag A Bleiblo
Cryopreservation of sperm is routinely used in assisted reproduction technology (ART) for male fertility preservation. However, this method has been associated with oxidative stress and DNA fragmentation that may impair sperm quality. Additionally, antioxidant interventions such as melatonin supplementation have not been thoroughly explored in this setting. Although Libya is reported to have one of the highest global prevalence rates of male infertility, Libya-specific data remain limited. This study aimed to determine the effect of a single freeze-thaw cycle on sperm DNA fragmentation and oxidative stress markers, and to evaluate whether melatonin has an impact on post-thaw oxidation profiles. This prospective cohort study was conducted at the Fertility and Reproductive Medicine Center, Beirut Hospital, Benghazi. Semen samples of 104 normozoospermic Libyans were evaluated before and after freezing. DNA fragmentation index (DFI) was measured by sperm chromatin dispersion (SCD) test, and reactive oxygen species (ROS) were quantified by using luminol-enhanced chemiluminescence. In a subset of ejaculates, aliquots were supplemented with 2 mM of melatonin prior to cryopreservation. Cryopreservation was associated with a statistically significant increase in DFI (46.3 ± 18.3% to 60.0 ± 23.0%; p < 0.001) and ROS levels (3.2 × 10³ to 14.7 × 10³ RLU/s; p < 0.001). Smokers presented significantly higher DFI at both pre-freeze and post-thaw evaluations (p < 0.001). We detected a positive correlation between ROS and post-thaw DFI (r = 0.68; p < 0.001). Melatonin-treated samples exhibited moderate but significant differences in ROS (12%, p = 0.045) and DFI (11%, p = 0.004) compared to untreated aliquots. These findings suggested that the freeze-thaw process may contribute to oxidative and genomic stress in spermatozoa, while melatonin supplementation appears to provide limited protection. Larger, multicenter studies incorporating ART endpoints are required to determine the potential translational relevance of these findings.
精子冷冻保存通常用于辅助生殖技术(ART)中保存男性生育能力。然而,这种方法与氧化应激和DNA断裂有关,可能会损害精子质量。此外,在这种情况下,抗氧化干预如褪黑激素补充还没有得到彻底的探索。尽管据报道,利比亚是全球男性不育症患病率最高的国家之一,但利比亚的具体数据仍然有限。本研究旨在确定单次冻融循环对精子DNA断裂和氧化应激标志物的影响,并评估褪黑激素是否对解冻后氧化特征有影响。这项前瞻性队列研究在班加西贝鲁特医院生育和生殖医学中心进行。在冷冻前后对104名无精子的利比亚人的精液样本进行了评估。采用精子染色质分散(SCD)法测定DNA片段化指数(DFI),采用鲁米诺增强化学发光法测定活性氧(ROS)。在射精的一个子集中,在冷冻保存之前,等量的射精中补充了2mm的褪黑激素。与未处理组相比,冷冻保存与DFI(46.3±18.3%至60.0±23.0%;p p p p p = 0.045)和DFI (11%, p = 0.004)的增加有统计学意义。这些发现表明,冻融过程可能导致精子的氧化和基因组应激,而补充褪黑激素似乎提供有限的保护。需要更大规模的多中心研究纳入ART终点,以确定这些发现的潜在转译相关性。
{"title":"Cryopreservation increases sperm DNA fragmentation in normozoospermic Libyan men: the role of oxidative stress and the protective effect of melatonin.","authors":"Asma A Al Bijou, Jehan A Ilfergani, Tarek S Bader, Muetaz M Feetouri, Ibtihag S Alogali, Yousef M A Hasen, Mahmoud A Aloriby, Farag A Bleiblo","doi":"10.1080/19932820.2025.2569151","DOIUrl":"10.1080/19932820.2025.2569151","url":null,"abstract":"<p><p>Cryopreservation of sperm is routinely used in assisted reproduction technology (ART) for male fertility preservation. However, this method has been associated with oxidative stress and DNA fragmentation that may impair sperm quality. Additionally, antioxidant interventions such as melatonin supplementation have not been thoroughly explored in this setting. Although Libya is reported to have one of the highest global prevalence rates of male infertility, Libya-specific data remain limited. This study aimed to determine the effect of a single freeze-thaw cycle on sperm DNA fragmentation and oxidative stress markers, and to evaluate whether melatonin has an impact on post-thaw oxidation profiles. This prospective cohort study was conducted at the Fertility and Reproductive Medicine Center, Beirut Hospital, Benghazi. Semen samples of 104 normozoospermic Libyans were evaluated before and after freezing. DNA fragmentation index (DFI) was measured by sperm chromatin dispersion (SCD) test, and reactive oxygen species (ROS) were quantified by using luminol-enhanced chemiluminescence. In a subset of ejaculates, aliquots were supplemented with 2 mM of melatonin prior to cryopreservation. Cryopreservation was associated with a statistically significant increase in DFI (46.3 ± 18.3% to 60.0 ± 23.0%; <i>p </i>< 0.001) and ROS levels (3.2 × 10³ to 14.7 × 10³ RLU/s; <i>p </i>< 0.001). Smokers presented significantly higher DFI at both pre-freeze and post-thaw evaluations (<i>p</i> < 0.001). We detected a positive correlation between ROS and post-thaw DFI (r = 0.68; <i>p </i>< 0.001). Melatonin-treated samples exhibited moderate but significant differences in ROS (12%, <i>p</i> = 0.045) and DFI (11%, <i>p</i> = 0.004) compared to untreated aliquots. These findings suggested that the freeze-thaw process may contribute to oxidative and genomic stress in spermatozoa, while melatonin supplementation appears to provide limited protection. Larger, multicenter studies incorporating ART endpoints are required to determine the potential translational relevance of these findings.</p>","PeriodicalId":49910,"journal":{"name":"Libyan Journal of Medicine","volume":"20 1","pages":"2569151"},"PeriodicalIF":1.7,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12523456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145287555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}